Generalized sarcoidosis and severe thrombocytopenic purpura: clinical observation and literature review | Zendy

Liubov A. Ponomareva | Zendy; L. A. Panchenko | Zendy; А Б Пономарев | Zendy; Е. Н. Попова | Zendy; Yu.V. Putincev | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Generalized sarcoidosis and severe thrombocytopenic purpura: clinical observation and literature review

Author(s) -

Liubov A. Ponomareva,

L. A. Panchenko,

А Б Пономарев,

Е. Н. Попова,

Yu.V. Putincev

Publication year - 2020

Publication title -

clinical review for general practice

Language(s) - English

Resource type - Journals

eISSN - 2782-5671

pISSN - 2713-2552

DOI - 10.47407/kr2020.1.2.00011

Subject(s) - sarcoidosis , medicine , thrombocytopenic purpura , immunology , etiology , pancytopenia , disease , systemic disease , purpura (gastropod) , dermatology , pathology , immune system , immunopathology , bone marrow , ecology , biology

Sarcoidosis is a disease of an unknown etiology and is characterized by a wide range of clinical manifestations due to granulomatous damage of the lungs and other organs. Hematologic disorders in sarcoidosis are represented by different variants of pancytopenia, while autoimmune thrombocytopenic purpura is rare. Hemorrhagic syndrome with critical thrombocytopenia in blood of a patient with systemic sarcoidosis (damage to the lungs, nervous system, skin) coincided with an episode of a viral infection with symptoms of COVID-19 and the detection of an increased titer of antibodies to SARS-CoV-2 in the blood. In our paper we described the clinical features of the disease, medical treatment. The issues of managing patients with sarcoidosis during a pandemic time are discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research